or Try an Advanced Search...

    Hepatitis C Virus Stocks List

    Symbol Grade Name % Change
    INO F Inovio Pharmaceuticals, Inc. -2.77
    NNVC F NanoViricides, Inc. -2.67
    RGLS F Regulus Therapeutics Inc. 0.64
    SCYX F SCYNEXIS, Inc. -4.03
    IONS F Ionis Pharmaceuticals, Inc. -2.47
    ENTA F Enanta Pharmaceuticals, Inc. 5.60
    VRTX D Vertex Pharmaceuticals Incorporated 1.01
    BMY B Bristol-Myers Squibb Company 2.24
    ABBV A AbbVie Inc. -0.26
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Hepatitis C Hepatitis B Hepatitis B Virus Infection Hepatitis C Virus Infection Immunodeficiency Infectious Diseases Influenza Medicine S&P 500 Autoimmune Disease Biopharmaceutical Cancer Chemical Compounds Coronavirus Cyclophilin Cyclopropanes Depressive Disorder Diabetes Dystrophy

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis C Virus stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 18.18
    MEDX D Horizon Kinetics Medical ETF 12.54
    PPH D Market Vectors Pharmaceutical ETF 10.98
    XLV C SPDR Select Sector Fund - Health Care 10.09
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.94
    View all Hepatitis C Virus ETFs...
    Compare ETFs
    Compare FTXH to BOTZ Compare FTXH to MEDX Compare PPH to BOTZ

        Hepatitis C Virus Stocks Recent News

        Date Stock Title
        Oct 1 ABBV Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
        Oct 1 BMY PRME Stock Rises 11.8% on Collaboration With Bristol Myers
        Oct 1 ABBV AbbVie withdraws Exviera from EU market for commercial reasons
        Oct 1 BMY A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
        Oct 1 BMY BMS and Prime ink potential $3.5bn deal to develop T cell therapies
        Oct 1 IONS Ionis gets U.S. FDA fast track designation for its Alexander disease treatment
        Oct 1 BMY Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend
        Oct 1 ABBV AbbVie to Host Third-Quarter 2024 Earnings Conference Call
        Oct 1 INO INOVIO to Present at Upcoming Scientific Conferences
        Oct 1 IONS Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
        Oct 1 VRTX 5 FDA decisions to watch in the fourth quarter
        Oct 1 BMY 5 FDA decisions to watch in the fourth quarter
        Oct 1 BMY Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
        Sep 30 VRTX Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing
        Sep 30 BMY Bristol Myers gets $6.4B Celgene CVR case dismissed: report
        Sep 30 BMY Sector Update: Health Care Stocks Advance Late Afternoon
        Sep 30 BMY US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
        Sep 30 BMY Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
        Sep 30 BMY Prime Medicine stock rallies 15% on Bristol Myers deal, drug updates
        Sep 30 ABBV AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Hepatitis C Hepatitis B Hepatitis B Virus Infection Hepatitis C Virus Infection Immunodeficiency Infectious Diseases Influenza Medicine S&P 500 Autoimmune Disease Biopharmaceutical Cancer Chemical Compounds Coronavirus Cyclophilin Cyclopropanes Depressive Disorder Diabetes Dystrophy
        Hepatitis C Virus

        Hepatitis C virus (HCV) is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. Hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans.

        More about Hepatitis C Virus
        Browse All Tags